Phase II Randomized Open Label Study of Neo-Adjuvant Degarelix vs. LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Degarelix (Primary) ; Bicalutamide; Gonadotropin releasing hormone stimulants
- Indications Prostate cancer
- Focus Pharmacodynamics
- Acronyms Degarelix Pre-Op
- 18 Oct 2016 Results assessing treatment effect on intratumoral dihydrotestosterone levels published in the Clinical cancer research: an official journal of the American Association for Cancer Research
- 10 May 2016 Results (n=39) presented at the 111th Annual Meeting of the American Urological Association.
- 21 Dec 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.